Results 111 to 120 of about 64,359 (278)

Cahiers de civilisation médiévale 63 (fascicules 250-251)

open access: yes, 2021
Parution du dernier numéro des Cahiers de civilisation médiévale, 63e année, numéros 252, octobre-décembre 2020. SOMMAIRE Robert MAXWELL, Le doute, la crédulité et la pratique artistique au XIIe siècle, 211 Peter SCOTT BROWN, Détruire un autel : Amat
Cahiers de civilisation médiévale
core  

ABL kinase‐dependent phosphorylation of SH proteins promotes their direct interaction with CRK family SH2 domains

open access: yesFEBS Letters, EarlyView.
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens   +8 more
wiley   +1 more source

Cahiers de civilisation médiévale 63 (249)

open access: yes, 2020
Parution du dernier numéro des Cahiers de civilisation médiévale, 63e année, numéro 249, janvier-mars 2020. SOMMAIRE Amélie RIGOLLET, La rose comme gage vassalique : l’exemple des Briouze, seigneurs du Gower Brigitte ROUX et Marion UHLIG, L’invention
Cahiers de civilisation médiévale
core  

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

open access: yesMolecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce   +11 more
wiley   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Subtype‐specific enhancer RNAs define transcriptional regulators and prognosis in breast cancers

open access: yesMolecular Oncology, EarlyView.
This study employed machine learning methodologies to perform the subtype‐specific classification of RNA‐seq data sets, which are mapped on enhancers from TCGA‐derived breast cancer patients. Their integration with gene expression (referred to as ProxCReAM eRNAs) and chromatin accessibility profiles has the potential to identify lineage‐specific and ...
Aamena Y. Patel   +6 more
wiley   +1 more source

Cahiers de civilisation médiévale 61/3 (fascicule 243)

open access: yes, 2018
Voir la couverture  ICI  Parution du dernier numéro des Cahiers de civilisation médiévale, Le fascicule 243, livraison juillet-septembre 2018, tome 61 est disponible.
Cahiers de civilisation médiévale
core  

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

open access: yesMolecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano   +6 more
wiley   +1 more source

Cahiers de civilisation médiévale 60/2 (fascicule 238)

open access: yes, 2017
Voir la couverture ICI Parution du dernier numéro des Cahiers de civilisation médiévale, Le fascicule 238, livraison d'avril-juin 2017 du tome 60 est disponible.
Cahiers de civilisation médiévale
core  

COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells

open access: yesMolecular Oncology, EarlyView.
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy